Funding for this research was provided by:
Guangxi Clinical Research Center for Colorectal Cancer (AD19245197)
the Guangxi Science and Technology Department Project (Guike AB16380202)
the National Natural Science Foundation of China (81973533)
2019 Guangxi University High-level Innovation Team and the Project of Outstanding Scholars Program, and Guangxi Science and Technology Project (2019AC03004)
Received: 22 April 2020
Accepted: 27 November 2020
First Online: 7 January 2021
Ethics approval and consent to participate
: The protocol of this study was approved by the Ethics and Human Subject Committee of Guangxi Medical University Cancer Hospital (ID: LW2018039), and all experiments and methods met the standards of the relevant guidelines and regulations.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.